12 unchanged sentences
First Quarter $ 28.49 $ 22.99
−Removed: As of July 21, 2022, there were 170 holders of record of our common stock.
+Added: As of August 2, 2023, there were 169 holders of record of our common stock.
We did not declare any cash dividends on our common stock during our last three fiscal years.
1 unchanged sentence
Performance Graph
−Removed: The graph below matches AngioDynamics, Inc.’s cumulative 5-year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index, the RDG SmallCap Medical Devices index, and the NASDAQ Medical Equipment index.
+Added: The graph below matches AngioDynamics, Inc.’s cumulative 5-year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index, the RDG SmallCap Medical Devices index, S&P 500 Health Care index and the NASDAQ Medical Equipment index.
The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from May 31, 2018 to May 31, 2023.
The stock price performance included in this graph is not necessarily indicative of future stock price performance.
−Removed: Selected Financial Data.
−Removed: Information required by this Item 6 is not included as we are electing to exclude this information pursuant to Regulation S-K Item 301, as amended.
−Removed: For financial data and discussion of our results of operations and financial position, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 8 “Financial Statements and Supplementary Data” contained in this Annual Report on Form 10-K.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.